OTCMKTS:RSLS ReShape Lifesciences - RSLS News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $2.80 -0.13 (-4.44%) (As of 03/30/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.77▼$3.0650-Day Range$2.66▼$17.0452-Week Range$2.49▼$77.00Volume40,729 shsAverage Volume207,757 shsMarket Capitalization$1.46 millionP/E RatioN/ADividend YieldN/APrice Target$2.88 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address RSLS Media Mentions By Week RSLS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RSLS News Sentiment▼-0.760.60▲Average Medical News Sentiment RSLS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RSLS Articles This Week▼20▲RSLS Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineReshape Lifesciences Stock (NASDAQ:RSLS), Guidance and Forecastbenzinga.com - March 30 at 3:20 PMReShape Lifesciences® To Delay Year Ended December 31, 2022 Earnings Release and Conference Callfinance.yahoo.com - March 29 at 1:00 AMReShape Lifesciences Announces Formation of International Scientific Advisory Boardfinance.yahoo.com - March 23 at 9:05 AMReShape Lifesciences® to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Updatefinance.yahoo.com - March 22 at 9:01 AMReShape Lifesciences(R) to Present at the Q2 Virtual Investor Summitmarketwatch.com - March 17 at 11:28 PMReShape Lifesciences® to Present at the Q2 Virtual Investor Summitfinance.yahoo.com - March 15 at 8:39 AMReShape Lifesciences Shares Drop 60% After Public Offering Pricesmarketwatch.com - February 6 at 11:09 AMWhy ReShape Lifesciences (RSLS) Shares Are Plummetingmsn.com - February 6 at 11:09 AMReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offeringfinance.yahoo.com - February 6 at 11:09 AMReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offeringfinance.yahoo.com - February 6 at 11:09 AMReShape Lifesciences Stock More Than Doubles to $14.39marketwatch.com - February 4 at 12:15 AMLooking Into Reshape Lifesciences's Recent Short Interestmsn.com - January 4 at 2:15 PMReshape Lifesciences Earnings Perspective: Return On Capital Employedmsn.com - December 27 at 1:32 PMReShape Lifesciences Announces 1-for-50 Reverse Stock Split Effective as of Commencement of Trading on December 23, 2022finance.yahoo.com - December 22 at 8:45 AMReShape Lifesciences™ to Announce Financial Results for the Third Quarter Ended September 30, 2022, and Provide Corporate Updatefinance.yahoo.com - November 8 at 11:47 AMReShape Lifesciences Announces $750,000 Registered Direct Offeringfinance.yahoo.com - November 8 at 11:47 AMReShape Lifesciences™ Presents Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at ObesityWeek®finance.yahoo.com - November 3 at 10:55 AMReShape Lifesciences™ Announces That the ASMBS and IFSO Have Issued Updated Guidelines on Indications for Metabolic and Bariatric Surgery, Including the Lap-Band®finance.yahoo.com - October 31 at 10:25 AMReShape Lifesciences™ Announces Publication of Data on Proprietary Diabetes Bloc-Stim Neuromodulation™ (DBSN™) System in Peer Reviewed, Frontiers in NeuroSciencefinance.yahoo.com - October 25 at 10:36 AMReShape Lifesciences™ Announces Release of a Positive Consensus Statement on Lap-Band® Use and Lap-Band® Aftercare Management by the American Society of Metabolic and Bariatric Surgery (ASMBS)finance.yahoo.com - October 20 at 9:28 AMReShape Lifesciences Appoints Seasoned Sales and Marketing Executive, Nick Ansari, as Senior Vice President of Global Commercial Operationsfinance.yahoo.com - August 23 at 5:14 PMReShape Lifesciences Inc. Reports Q2 Net Loss of $7.8Minvesting.com - August 16 at 8:18 PMReShape Lifesciences(TM) Receives FDA 510(k) Clearance for the GIBI HD(TM) Calibration Tubes for use in Gastric and Bariatric Proceduresmarketwatch.com - August 12 at 1:50 AMReShape Lifesciences' GIBI HD Calibration Tubes Scores FDA Approval For Tummy Tuck Proceduresfinance.yahoo.com - August 10 at 9:20 PMReShape Lifesciences™ to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide Corporate Updatefinance.yahoo.com - August 10 at 9:20 PMReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceedsfinance.yahoo.com - June 17 at 5:12 PMReshape Lifesciences (NASDAQ:RSLS), Analyst Ratings, Price Targets, Predictionsbenzinga.com - May 30 at 5:34 AMReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecare™finance.yahoo.com - May 26 at 12:23 PMReShape Lifesciences Inc.'s (RSLS) CEO Bart Bandy on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 23 at 7:16 PMReShape Lifesciences earnings preview: what Wall Street is expectingmarkets.businessinsider.com - May 22 at 9:49 AMReShape Lifesciences™ Announces Vernon Vincent to be Recognized as the Distinguished Industry Partner at the ASMBS 2022 LEAD Gala and Awardsfinance.yahoo.com - May 19 at 3:30 PMReShape Lifesciences™ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Updatefinance.yahoo.com - May 16 at 10:57 AMReShape Lifesciences to Present at the Q2 Investor Summitfinance.yahoo.com - April 26 at 8:45 AMEarnings Update: ReShape Lifesciences Inc. (NASDAQ:RSLS) Just Reported And Analysts Are Trimming Their Forecastsfinance.yahoo.com - March 31 at 3:53 PMReShape Lifesciences Inc. (RSLS)uk.finance.yahoo.com - March 28 at 11:03 PMReShape Lifesciences GAAP EPS of $5.00, revenue of $13.69Mseekingalpha.com - March 28 at 6:03 PMReShape Lifesciences™ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Updatefinance.yahoo.com - March 28 at 6:03 PMEarnings Preview For Reshape Lifesciencesbenzinga.com - March 27 at 10:30 PMReShape Lifesciences™ Experiences Continued Momentum of Direct-to-Consumer Marketing Campaign for the Lap-Band®finance.yahoo.com - March 24 at 2:53 PMReShape Lifesciences to Participate in Investor Conferences in Marchfinance.yahoo.com - March 9 at 8:40 AMReShape Lifesciences™ to Participate in the American Society for Metabolic and Bariatric Surgery’s (ASMBS) Leadership Academy and re-UNITED Meeting January 19-22, 2022 in Las Vegasfinance.yahoo.com - January 18 at 9:18 AMReShape Lifesciences Strengthens Leadership Team with Appointment of Michael Bordainick as Senior Vice President, Commercial Operationsfinance.yahoo.com - January 13 at 9:46 AMReShape Lifesciences to Webcast Live at Life Sciences Investor Forum on December 16thfinance.yahoo.com - December 9 at 10:44 AMReShape Lifesciences Witnesses Great Success with Direct-to-Consumer Marketing Campaignfinance.yahoo.com - November 16 at 12:53 PMReShape Lifesciences Reports Third Quarter and Nine Month 2021 Financial and Operational Resultsfinance.yahoo.com - November 11 at 9:37 AMReShape Lifesciences to Report Third Quarter 2021 Financial and Operational Results on Thursday, November 11, 2021finance.yahoo.com - November 8 at 10:11 AMReShape Lifesciences to Present at Dawson James 6th Annual Small Cap Growth Conferencefinance.yahoo.com - October 19 at 10:31 AMReShape Lifesciences to Present at Dawson James 6th Annual Small Cap Growth Conferencefinance.yahoo.com - October 19 at 10:31 AMReShape Launches National Advertising Campaign for Flagship Product, Lap-Band®finance.yahoo.com - October 12 at 10:09 AMReShape Lifesciences™ Featured in BioTuesdaysfinance.yahoo.com - September 23 at 9:17 AM Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (OTCMKTS:RSLS) was last updated on 3/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.